Long-term Activation of c-Jun N-terminal Kinase through Receptor Interacting Protein is Associated with DNA

Jeong Ho Seok1, Kyeong Ah Park, Hee Sun Byun

  • 1Department of Pharmacology, Research Institute for Medical Sciences, College of Medicine, Chungnam National University, Daejeon 301-131, Korea.

Insights

Receptor interacting protein (RIP) mediates sustained c-Jun N-terminal kinase (JNK) activation by DNA damage, influencing cell death. This pathway, distinct from TNF signaling, requires ATM activity and is crucial for specific genotoxic stress responses.

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Stress response pathways

Background:

  • c-Jun N-terminal kinase (JNK) activation is a key cellular response to genotoxic stress and tumor necrosis factor (TNF).
  • The precise signaling pathways and cellular sensors initiating JNK activation under genotoxic stress remain largely unidentified.
  • Understanding these pathways is crucial for deciphering cell fate determination following DNA damage.

Purpose of the Study:

  • To identify the signaling molecules and pathways involved in JNK activation by DNA damaging agents.
  • To investigate the role of receptor interacting protein (RIP) and ATM in mediating JNK activation by different types of genotoxic stress.
  • To determine the contribution of sustained JNK activation to DNA damage-induced cell death.

Main Methods:

  • Treatment of cells with various DNA damaging agents (adriamycin, 1-beta-D-arabinofuranosylcytosine, N-methyl-N-nitro-N-nitrosoguanidine, UV light).
  • Assessment of JNK activation kinetics and dependence on RIP and ATM.
  • Inhibition of JNK using SP-600125 to evaluate its role in cell death.

Main Results:

  • Receptor interacting protein (RIP) is essential for sustained JNK activation by adriamycin and 1-beta-D-arabinofuranosylcytosine, but not by N-methyl-N-nitro-N-nitrosoguanidine or UV.
  • Sustained JNK activation by these agents is mediated by ATM (ataxia telangiectasia) activity, independent of TNF receptor signaling.
  • JNK inhibition blocked adriamycin-induced cell death but not N-methyl-N-nitro-N-nitrosoguanidine-induced cell death.

Conclusions:

  • Sustained JNK activation, mediated by RIP and ATM, plays a significant role in DNA damage-induced cell death.
  • The duration of JNK activation dictates the cellular response and fate following genotoxic stress.
  • This study elucidates a novel pathway for DNA damage signaling through RIP and ATM to JNK.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...